Form 8-K - Current report:
SEC Accession No. 0001437749-24-018539
Filing Date
2024-05-29
Accepted
2024-05-29 07:00:27
Documents
14
Period of Report
2024-05-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20240528_8k.htm   iXBRL 8-K 27840
  Complete submission text file 0001437749-24-018539.txt   148492

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240528.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240528_def.xml EX-101.DEF 10354
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240528_lab.xml EX-101.LAB 13837
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240528_pre.xml EX-101.PRE 10349
17 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240528_8k_htm.xml XML 2552
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 24993980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)